These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8613997)

  • 1. Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: new tricks for an old dog?
    Gelmann EP
    J Natl Cancer Inst; 1996 Mar; 88(5):224-6. PubMed ID: 8613997
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
    Kang Y; Cortina R; Perry RR
    J Natl Cancer Inst; 1996 Mar; 88(5):279-84. PubMed ID: 8614006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for the ideal SERM.
    Poletti A
    Pharmacol Res; 1999 May; 39(5):333. PubMed ID: 10328989
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular aspects of different mechanisms of tamoxifen resistance].
    Bachmann-Moisson N; Barberi-Heyob M; Merlin JL
    Bull Cancer; 1997 Jan; 84(1):69-75. PubMed ID: 9180863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In search of the perfect SERM: beyond tamoxifen and raloxifene.
    McNeil C
    J Natl Cancer Inst; 1998 Jul; 90(13):956-7. PubMed ID: 9665139
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen for patients with estrogen receptor-negative breast cancer.
    Swain SM
    J Clin Oncol; 2001 Sep; 19(18 Suppl):93S-97S. PubMed ID: 11560981
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of transforming growth factor beta expression and induction of apoptosis by tamoxifen in ER positive and ER negative breast cancer cells.
    Benson JR; Baum M
    Br J Cancer; 1996 Sep; 74(6):993-4. PubMed ID: 8826875
    [No Abstract]   [Full Text] [Related]  

  • 9. Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.
    Xu Z; Huang B; Liu J; Wu X; Luo N; Wang X; Zheng X; Pan X
    Toxicology; 2018 Dec; 410():231-246. PubMed ID: 30153467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
    Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
    Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.
    Newby JC; Johnston SR; Smith IE; Dowsett M
    Clin Cancer Res; 1997 Sep; 3(9):1643-51. PubMed ID: 9815855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer.
    al-Alwan NA; al-Kubaisy W; al-Rawaq K
    East Mediterr Health J; 2000; 6(2-3):475-82. PubMed ID: 11556039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: In search of the perfect SERM: beyond tamoxifen and raloxifene.
    Williams GM
    J Natl Cancer Inst; 1998 Nov; 90(21):1671. PubMed ID: 9811319
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer.
    Kulkoyluoglu E; Madak-Erdogan Z
    Steroids; 2016 Oct; 114():41-47. PubMed ID: 27394959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen in early breast cancer.
    Arriagada R
    Lancet; 1998 Aug; 352(9125):403-4. PubMed ID: 9717953
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of transcription factor Snail1 in the regulation of hormonal sensitivity of in vitro cultured breast cancer cells].
    Andreeva OE; Shcherbakov AM; Shatskaia VA; Krasil'nikov MA
    Vopr Onkol; 2012; 58(1):71-6. PubMed ID: 22629832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.
    Cappelletti V; Veneroni S; Coradini D; Oriana S; Tomasic G; Younes M; Daidone MG
    J Natl Cancer Inst; 2003 Apr; 95(8):629-30. PubMed ID: 12697859
    [No Abstract]   [Full Text] [Related]  

  • 18. The estrogen receptor: a model for molecular medicine.
    Jensen EV; Jordan VC
    Clin Cancer Res; 2003 Jun; 9(6):1980-9. PubMed ID: 12796359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen in early breast cancer.
    Bryce CJ
    Lancet; 1998 Aug; 352(9125):403. PubMed ID: 9717952
    [No Abstract]   [Full Text] [Related]  

  • 20. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells.
    Shen F; Xue X; Weber G
    Anticancer Res; 1999; 19(3A):1657-62. PubMed ID: 10470097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.